CD44 and breast carcinoma: In a previous study in our laboratory, MCF-7SC breast cancer cells were found to possess an increased population of CD44+/CD24− cells, higher ALDH levels, reduced ROS levels, overexpressed drug efflux proteins (MDR1 and MRP1), increased mammosphere formation capacity, and increased migration and invasion [3].